These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25612678)

  • 1. Quercetin Increase the Chemosensitivity of Breast Cancer Cells to Doxorubicin Via PTEN/Akt Pathway.
    Li SZ; Qiao SF; Zhang JH; Li K
    Anticancer Agents Med Chem; 2015; 15(9):1185-9. PubMed ID: 25612678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
    Zhong T; Xu F; Xu J; Liu L; Chen Y
    Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
    Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
    Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
    Shi X; Valizadeh A; Mir SM; Asemi Z; Karimian A; Majidina M; Safa A; Yosefi B
    Eur J Pharmacol; 2020 Aug; 880():173138. PubMed ID: 32416187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of quercetin on doxorubicin cytotoxicity in human breast cancer cells.
    Li SZ; Li K; Zhang JH; Dong Z
    Anticancer Agents Med Chem; 2013 Feb; 13(2):352-5. PubMed ID: 22721393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
    Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
    Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling.
    Chen Y; Sun Y; Chen L; Xu X; Zhang X; Wang B; Min L; Liu W
    Mol Med Rep; 2013 May; 7(5):1579-84. PubMed ID: 23546450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation.
    Li S; Zhao Q; Wang B; Yuan S; Wang X; Li K
    Phytother Res; 2018 Aug; 32(8):1530-1536. PubMed ID: 29635751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it.
    Li S; Yuan S; Zhao Q; Wang B; Wang X; Li K
    Biomed Pharmacother; 2018 Apr; 100():441-447. PubMed ID: 29475141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
    Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
    Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
    Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y
    J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer.
    Li K; Liu W; Zhao Q; Wu C; Fan C; Lai H; Li S
    Phytother Res; 2019 Jun; 33(6):1658-1669. PubMed ID: 30945389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN augments doxorubicin-induced apoptosis in PTEN-null Ishikawa cells.
    Wan X; Li J; Xie X; Lu W
    Int J Gynecol Cancer; 2007; 17(4):808-12. PubMed ID: 17359293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
    Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
    Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quercetin induces apoptosis of human breast cancer cells by activiting PTEN and inhibiting PI3K/AKT and JNK signaling pathways].
    Zhu S; Yu W; Bi L; Qin F; Li J; Zeng H; Lu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Aug; 38(8):714-720. PubMed ID: 35851085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN inhibitor bpV(HOpic) confers protection against ionizing radiation.
    Chauhan A; Sah DK; Kumari N; Kalra N; Soni R; Bhatt AN
    Sci Rep; 2021 Jan; 11(1):1720. PubMed ID: 33462262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.
    Steelman LS; Navolanic PM; Sokolosky ML; Taylor JR; Lehmann BD; Chappell WH; Abrams SL; Wong EW; Stadelman KM; Terrian DM; Leslie NR; Martelli AM; Stivala F; Libra M; Franklin RA; McCubrey JA
    Oncogene; 2008 Jul; 27(29):4086-95. PubMed ID: 18332865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
    Shen J; Zhang W; Wu J; Zhu Y
    Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.